-
EP3178849
European procedure
Extract from the Register of European Patents
EP About this file: EP3178849
| EP3178849 - COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.01.2020 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 15.02.2019 | ||
| Former | Grant of patent is intended Status updated on 08.02.2019 | ||
| Former | Examination is in progress Status updated on 22.01.2019 | ||
| Former | Grant of patent is intended Status updated on 12.09.2018 | ||
| Former | Examination is in progress Status updated on 02.02.2018 | ||
| Former | Request for examination was made Status updated on 28.12.2017 | ||
| Former | The application has been published Status updated on 12.05.2017 | Most recent event Tooltip | 03.10.2024 | Change - lapse in a contracting state State(s) deleted from list of lapses: AL | published on 06.11.2024 [2024/45] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543-4000 / US | [2017/24] | Inventor(s) | 01 /
KORMAN, Alan J. 700 Bay Road Redwood City, CA 94063 / US | 02 /
LONBERG, Nils 700 Bay Road Redwood City, CA 94063 / US | 03 /
FONTANA, David J. 1201 Eastlake Avenue E. Seattle, WA 98102 / US | 04 /
GUTIERREZ, Andres A. Route 206&Province Line Road Princeton, NJ 08543 / US | 05 /
SELBY, Mark J. 700 Bay Road Redwood City, CA 94063 / US | 06 /
LEWIS, Katherine E. 1201 Eastlake Avenue E. Seattle, WA 98102 / US | [2017/24] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2017/24] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 16197459.7 | 18.09.2014 | [2017/24] | Priority number, date | US201361880606P | 20.09.2013 Original published format: US 201361880606 P | US201462014471P | 19.06.2014 Original published format: US 201462014471 P | [2017/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3178849 | Date: | 14.06.2017 | Language: | EN | [2017/24] | Type: | B1 Patent specification | No.: | EP3178849 | Date: | 20.03.2019 | Language: | EN | [2019/12] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.02.2017 | Classification | IPC: | A61K39/395, A61P35/00, C07K16/28 | [2018/35] | CPC: |
C07K16/2818 (EP,IL,KR,US);
C07K16/2803 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US);
A61K2039/505 (EP,IL,KR,US);
A61K2039/507 (EP,IL,US);
A61K2039/54 (IL,US);
A61K2039/545 (EP,IL,KR,US);
C07K2317/21 (IL,US);
C07K2317/24 (EP,IL,US);
C07K2317/53 (IL,US);
C07K2317/56 (IL,US);
C07K2317/565 (IL,US);
|
| Former IPC [2017/24] | C07K16/28, A61K39/395, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/04] |
| Former [2017/24] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | KOMBINATION AUS ANTI-LAG-3-ANTIKÖRPERN UND ANTI-PD-1-ANTIKÖRPERN ZUR BEHANDLUNG VON TUMOREN | [2017/24] | English: | COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS | [2017/24] | French: | COMBINAISON D'ANTICORPS ANTI-LAG-3 ET D'ANTICORPS ANTI-PD-1 POUR TRAITER DES TUMEURS | [2017/24] | Examination procedure | 07.11.2016 | Date on which the examining division has become responsible | 14.12.2017 | Amendment by applicant (claims and/or description) | 14.12.2017 | Examination requested [2018/04] | 06.02.2018 | Despatch of a communication from the examining division (Time limit: M04) | 18.06.2018 | Reply to a communication from the examining division | 13.09.2018 | Communication of intention to grant the patent | 18.01.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 18.01.2019 | Fee for grant paid | 18.01.2019 | Fee for publishing/printing paid | 07.02.2019 | Information about intention to grant a patent | 07.02.2019 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP14786389.8 / EP3046939 | Divisional application(s) | EP18209399.7 / EP3508502 | EP23167891.3 / EP4249065 | Opposition(s) | 02.01.2020 | No opposition filed within time limit [2020/09] | Fees paid | Renewal fee | 07.11.2016 | Renewal fee patent year 03 | 12.09.2017 | Renewal fee patent year 04 | 11.09.2018 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2024/45] |
| Former [2022/31] | AL | 20.03.2019 | Documents cited: | Search | [I]WO2010019570 (MEDAREX INC [US], et al); | [T]WO2014008218 (BRISTOL MYERS SQUIBB CO [US]); | [E]WO2015016718 (BIONOVION HOLDING B V [NL]); | by applicant | WO2006121168 | US7943743 | US2011150892 | US8008449 | WO2013US40764 |